title: Intravenous sodium pyruvate protects against cerulein-induced acute pancreatitis.
authors.forename: Wieslaw
authors.initials: W
authors.lastname: Ziolkowski
authors.forename: Tomasz Henryk
authors.initials: TH
authors.lastname: Wierzba
authors.forename: Jan Jacek
authors.initials: JJ
authors.lastname: Kaczor
authors.forename: Robert Antoni
authors.initials: RA
authors.lastname: Olek
authors.forename: Michal
authors.initials: M
authors.lastname: Wozniak
authors.forename: Zbigniew
authors.initials: Z
authors.lastname: Kmieć
authors.forename: Andrzej
authors.initials: A
authors.lastname: Myśliwski
authors.forename: Jedrzej
authors.initials: J
authors.lastname: Antosiewicz
mesh_terms: D000208:Acute Disease; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D002108:Ceruletide / Q000633:toxicity; D008297:Male; D018384:Oxidative Stress / Q000187:drug effects; D010195:Pancreatitis / Q000139:chemically induced / Q000378:metabolism / Q000517:prevention & control*; D019289:Pyruvic Acid / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar
chemical_list: D000975:Antioxidants; D019289:Pyruvic Acid; D002108:Ceruletide